Literature DB >> 105239

A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes.

R Parfait, M P de Béthune, C Cocito.   

Abstract

Virginiamycin S (VS, a type B component of the synergistin group of antibiotics) is fluorescent in solution: the fluorescence intensity is proportional to VS concentration. The intensity of VS fluorescence was found to increase upon addition of 50S ribosomal subunits, and this variation (deltaI 416 nm) to be proportional to the concentration of 50S subunits. This new technique was, then, used to measure the binding reaction of VS to ribosomes. Similar patterns of linkage were obtained for ribosomes and large subunits, whereas very little fixation to 30S particles was detected. The binding reaction was virtually instantaneous at any temperature, and, for saturating VS, was not influenced by Mg++ concentration in the range 1 to 20 mM, nor by the replacement of 100 mM K+ with NH+4. The association constant of VS TO 50S particles was found to be KA=2.5 X 10(6)M-1, and from the Scatchard plot a v value of 0.9 was calculated, which points to a stoichiometric reaction leading to 1 mole VS bound per mole of 50S particles. Upon fixation of virginiamycin M (VM, a type A component of the synergistin group of antibiotics), the delta I of the VS-ribosome complex was increased, and a KA=15 x 10(6)M-1 was recorded for the association constant of VS to 50S particles. Such sixfold increase in the affinity of ribosomes for VS may account for the synergistic effect of the 2 virginiamycin components in sensitive bacteria.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 105239     DOI: 10.1007/bf00379728

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  17 in total

1.  The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits.

Authors:  C Cocito; M Di Giambattista
Journal:  Mol Gen Genet       Date:  1978-10-25

Review 2.  Inhibitors of protein synthesis.

Authors:  D Vazquez
Journal:  FEBS Lett       Date:  1974-03-23       Impact factor: 4.124

3.  Binding of the antibiotic vernamycin in Balpha to Escherichia coli ribosomes.

Authors:  H L Ennis
Journal:  Arch Biochem Biophys       Date:  1974-02       Impact factor: 4.013

4.  Virginiamycin: nomenclature.

Authors:  P Crooy; R De Neys
Journal:  J Antibiot (Tokyo)       Date:  1972-06       Impact factor: 2.649

5.  The properties of virginiamycin-resistant mutants of Bacillus subtilis.

Authors:  C Cocito; G Fraselle
Journal:  J Gen Microbiol       Date:  1973-05

6.  Formation of ribosomal particles in virginiamycin sensitive and resistant mutants of Bacillus subtilis.

Authors:  C Cocito
Journal:  Biochimie       Date:  1973       Impact factor: 4.079

7.  Virginiamycin M, a specific inhibitor of the acceptor site of ribosomes.

Authors:  C Cocito; A Kaji
Journal:  Biochimie       Date:  1971       Impact factor: 4.079

8.  Formation and decay of polyribosomes and ribosomes during the inhibition of protein synthesis and recovery.

Authors:  C Cocito
Journal:  Biochimie       Date:  1971       Impact factor: 4.079

9.  Cooperative and antagonistic interactions of peptidyl-tRNA and antibiotics with bacterial ribosomes.

Authors:  A Contreras; D Vázquez
Journal:  Eur J Biochem       Date:  1977-04-15

10.  A contrast variation study of Escherichia coli ribosomes reassembled from protonated and deuterated subunits.

Authors:  M H Koch; R Parfait; J Haas; R R Crichton; H B Stuhrmann
Journal:  Biophys Struct Mech       Date:  1978-07-12
View more
  7 in total

Review 1.  Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.

Authors:  C Cocito
Journal:  Microbiol Rev       Date:  1979-06

2.  The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits.

Authors:  C Cocito; M Di Giambattista
Journal:  Mol Gen Genet       Date:  1978-10-25

3.  Synergy of streptogramin antibiotics occurs independently of their effects on translation.

Authors:  Jonas Noeske; Jian Huang; Nelson B Olivier; Robert A Giacobbe; Mark Zambrowski; Jamie H D Cate
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

4.  Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M.

Authors:  R Parfait; C Cocito
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  Inhibitory action of virginiamycin components on cell-free systems for polypeptide formation from Bacillus subtilis.

Authors:  C Cocito; F Vanlinden
Journal:  Arch Microbiol       Date:  1983-08       Impact factor: 2.552

6.  Chemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domain.

Authors:  P Vannuffel; M Di Giambattista; C Cocito
Journal:  Nucleic Acids Res       Date:  1994-10-25       Impact factor: 16.971

Review 7.  The Mechanisms of Action of Ribosome-Targeting Peptide Antibiotics.

Authors:  Yury S Polikanov; Nikolay A Aleksashin; Bertrand Beckert; Daniel N Wilson
Journal:  Front Mol Biosci       Date:  2018-05-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.